Taro Pharmaceutical Industries Ltd (NYSE:TARO)

151.00
Delayed Data
As of May 27
 +12.44 / +8.98%
Today’s Change
103.33
Today|||52-Week Range
173.00
+1.90%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close138.56
Today’s open141.00
Day’s range-- - --
Volume154,208
Average volume (3 months)69,613
Market cap$5.9B
Dividend yield--
Data as of 05/27/2015

Growth & Valuation

Earnings growth (last year)+36.58%
Earnings growth (this year)+30.06%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+13.16%
P/E ratio--
Price/Sales6.47
Price/Book5.84

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-1.05-0.40%
PBYIPuma Biotechnology I...+1.69+0.85%
IDXXIDEXX Laboratories I...-0.47-0.34%
SGENSeattle Genetics Inc-0.31-0.72%
Data as of 3:59pm ET, 05/27/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$759.3M
Annual profit (last year)$360.4M
Net profit margin47.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Kal Sundaram
Chief Financial &
Accounting Officer, Group VP
Michael Kalb
Corporate headquarters
Haifa Bay, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers